Aciclovir controlled release - Avadel Pharmaceuticals

Drug Profile

Aciclovir controlled release - Avadel Pharmaceuticals

Alternative Names: Acyclovir controlled release (Micropump product) - Avadel Pharmaceuticals; Genvir; Viropump

Latest Information Update: 25 Jan 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Flamel Technologies
  • Class Antivirals; Hypoxanthines; Small molecules
  • Mechanism of Action DNA-directed DNA polymerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Herpes simplex virus infections

Most Recent Events

  • 24 Jan 2017 Discontinued - Phase-III for Herpes simplex virus infections in Europe (PO) (Avadel Pharmaceuticals pipeline, January 2017)
  • 24 Jan 2017 Discontinued - Preclinical for Herpes simplex virus infections in USA (PO) (Avadel Pharmaceuticals pipeline, January 2017)
  • 26 Jan 2011 No development reported - Phase-III for Herpes simplex virus infections in Europe (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top